Noteworthily, ERp29 overexpression was associated with mesenchymal-epithelial transition (MET) upregulation and epithelial morphogenesis8–10 as well as with epithelial-mesenchymal transition downregulation in cancer cells23. This evidence concerns the gene ERP29 and cancer.